Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
25%(2 trials)

Phase Distribution

Ph not_applicable
5
45%
Ph phase_1
1
9%
Ph early_phase_1
1
9%
Ph phase_4
4
36%

Phase Distribution

2

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
1(9.1%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 11 (9.1%)
Phase 44 (36.4%)
N/A5 (45.5%)

Trials by Status

unknown19%
withdrawn19%
completed873%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11